Syra Health Corp.
SYRA
$0.18
$0.0538.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.47% | -3.14% | 14.07% | 33.04% | 44.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.47% | -3.14% | 14.07% | 33.04% | 44.73% |
| Cost of Revenue | -25.14% | -9.83% | 8.24% | 36.11% | 54.12% |
| Gross Profit | 50.50% | 17.44% | 31.29% | 24.15% | 17.36% |
| SG&A Expenses | -30.74% | -34.99% | -28.03% | -4.82% | 19.03% |
| Depreciation & Amortization | -67.30% | -62.39% | -16.64% | 14.92% | 28.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.79% | -26.87% | -15.15% | 12.92% | 39.80% |
| Operating Income | 75.98% | 70.10% | 64.76% | 21.45% | -30.38% |
| Income Before Tax | 76.16% | 70.21% | 65.18% | 22.64% | -27.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 76.16% | 70.21% | 65.18% | 22.64% | -27.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.16% | 70.21% | 65.18% | 22.64% | -27.94% |
| EBIT | 75.98% | 70.10% | 64.76% | 21.45% | -30.38% |
| EBITDA | 76.21% | 70.23% | 65.40% | 21.96% | -30.41% |
| EPS Basic | 85.93% | 82.03% | 76.91% | 44.03% | 9.83% |
| Normalized Basic EPS | 85.95% | 82.04% | 76.93% | 44.06% | 9.87% |
| EPS Diluted | 85.93% | 82.03% | 76.91% | 44.03% | 9.83% |
| Normalized Diluted EPS | 85.95% | 82.04% | 76.93% | 44.06% | 9.87% |
| Average Basic Shares Outstanding | 56.97% | 69.47% | 70.51% | 63.36% | 55.17% |
| Average Diluted Shares Outstanding | 56.97% | 69.47% | 70.51% | 63.36% | 55.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |